Old Web
English
Sign In
Acemap
>
Paper
>
PCV40 - BUDGET IMPACT ANALYSIS OF RIVAROXABAN IN THE SECONDARY PREVENTION OF ACUTE CORONARY SYNDROMES IN GREECE
PCV40 - BUDGET IMPACT ANALYSIS OF RIVAROXABAN IN THE SECONDARY PREVENTION OF ACUTE CORONARY SYNDROMES IN GREECE
2018
P Stafylas
M Karaiskou
D. Arzoumanidou
N. Kolevris
A. Kotsanis
S. Chatzopoulos
Stephanie Stephens
O. Schoeman
Jean-Baptiste Briere
I. Kanakakis
Keywords:
Intensive care medicine
Rivaroxaban
Physical therapy
Medicine
budget impact
secondary prevention
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]